Home
About Us
About Us
Executive team
Corporate Structure
Brand
Our History
Our Culture
Contact us
News Releases
Business
R&D
Manufacturing
Distribution
Career
Talent concept
Cultivation of talents
Social Responsibility
Responsibility Management
Sustainability Report
CSR News
Investor Relations
Corporate Governance
Announcements
Financial Reports
Stock Price
Analyst Coverage
Notices of Replacement of Lost Certificates
Investor Relations Contacts
CN EN
Home
About Us
News Releases
Business
Career
Social Responsibility
Investor Relations
CR Home 中文版
Search
News Releases
Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the Consistency Evaluation of Quality and Efficacy of Generic Drugs
News Releases more >
Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the Consistency Evaluation of Quality and Efficacy of Generic Drugs 01-22
Novel Cancer Drug of CR Double-Crane Released and the Signing Ceremony between Haikou National Hi-tech Zone and CR Double-Crane Convened 11-12
NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC 10-09
A Delegation Led by Zhang Boli Visiting CR Sanjiu 10-08
Remaining Committed to Charity - The CR Healthy Village Program Keeping up the Good Work 09-17
CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chloride Injection Passing Consistency Evaluation of Generic Drugs 08-04
more >
Back to Top
Copyright © China Resources Pharmaceutical Group Limited 京ICP备17049899号 京公网安备11010502056191号 Technical Support：CR DIGITAL
Copyright © China Resources Pharmaceutical Group Limited
京ICP备17049899号
京公网安备11010502056191号
Technical Support：CR DIGITAL